Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct-Dec;6(4):154-160.
doi: 10.4103/sajc.sajc_181_17.

Oncology Gold Standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck

Govind Babu  1 , Ankur Bahl  2 , G S Bhattacharya  3 , K T Bhowmik  4 , P S Dattatraya  5 , Nikhil Ghadyalpatil  6 , S M Karandikar  7 , Padmaj Kulkarni  8 , Nithya Sridharan  9 , Purvish Parikh  10 , Kumar Prabhash  11 , T Raja  12 , S Rajasundaram  13 , S Subramanian  9 , Kaustav Talapatra  14 , Ashok Vaid  15 ; OGS SCCHN Group
Affiliations

Oncology Gold Standard® practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck

Govind Babu et al. South Asian J Cancer. 2017 Oct-Dec.

Abstract

We present the 2017 Oncology Gold Standard Practical Consensus Recommendation for use of monoclonal antibodies in the management of advanced squamous cell carcinoma of head neck region.

Keywords: Combination therapy; guidelines; outcome; survival; targeted therapy.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
EGFR binding with cetuximab and niomtuzumab (reproduced from Garrido et al Cancer Biol Ther 2011)
See this image and copyright information in PMC

References

    1. Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, et al. Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline. Pract Radiat Oncol. 2017;7:246–53. - PubMed
    1. Grégoire V, Lefebvre JL, Licitra L, Felip E EHNS-ESMO-ESTRO Guidelines Working Group. Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(Suppl 5):v184–6. - PubMed
    1. D’cruz A, Lin T, Anand AK, Atmakusuma D, Calaguas MJ, Chitapanarux I, et al. Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines. Oral Oncol. 2013;49:872–7. - PubMed
    1. NCCN Clinical Practice Guidelines in Oncology, Head and Neck Cancer Version 2.2017 of May 8. 2017. [Last accessed on 2017 Jun 14]. Available from: https://www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf .
    1. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide 2012. International Agency for Research on Cancer: World Health Organization. [Last accessed on 2016 Oct 03]. Available from: http://www.globocan.iarc.fr/Pages/fact_sheets_population.aspx .